Kinetics of cellular trafficking and cytotoxicity of 9.2.27-gelonin immunotoxins targeted against the high-molecular-weight melanoma-associated antigen

Cancer Immunology Immunotherapy

Volumn 47, Issue 6, 1999, Pages 321-329

  Chan, Michael C ^a   Murphy, Regina M ^a  

^a Department of Chemical Engineering ^*  (United States)

Author keywords

Cellular processing; Immunotoxins; Melanoma antigens

Indexed keywords

GELONIN; IMMUNOTOXIN; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 9 2 27; TRANSFERRIN RECEPTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; CANCER IMMUNOTHERAPY; HUMAN; HUMAN CELL; MATHEMATICAL MODEL; MELANOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BINDING SITES, ANTIBODY; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; IMMUNOTOXINS; MELANOMA; MODELS, BIOLOGICAL; MOLECULAR WEIGHT; NEOPLASM PROTEINS; PLANT PROTEINS; PROTEIN SYNTHESIS INHIBITORS; RABBITS; TUMOR CELLS, CULTURED;

EID: 0032991124     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050537     Document Type: Article

References (35)

1. Bailey JE, Ollis DF (1986) Biochemical engineering fundamentals, 2nd edn. McGraw-Hill, New York
2. Berd D, Herlyn M, Koprowski H, Mastrangelo MJ (1989) Flow cytometric determination of the frequency and heterogeneity of expression of human melanoma-associated antigens. Cancer Res 49:6840
3. Bumol TF, Wang QC, Reisfeld RA, Kaplan NO (1983) Monoclonal antibody and an antibody-toxin conjugate to a cell-surface proteoglycan of melanoma cells suppress in vivo tumor growth. Proc Natl Acad Sci USA 80:529
4. Caracotsios M, Stewart WE (1985) Sensitivity analysis of initial value problems with mixed ODEs and algebraic equations. Comp Chem Eng 9:359-365
5. Carlsson J, Drevin H, Axen R (1978) Protein thiolation and reversible protein-protein conjugation: N-succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. Biochem J 173:723
6. Ciechanover A, Schwartz AL, Dautry-Varsat A, Lodish HF (1983) Kinetics of internalization and recycling of transferrin and the transferrin receptor in a human hepatoma cell line. J Biol Chem 258:9681
7. Davies CDL, Lindmo T (1990) Hyperthermia-induced shedding and masking of melanoma-associated antigen. Int J Hyperthermia 6:1053
8. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70
9. Giacomini P, Natali P, Feroone S (1985) Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants. J Immunol 135:696
10. Godal A, Fodstad O, Morgan AC, Pihl A (1986) Human melanoma cell lines showing striking inherent differences in sensitivity to immunotoxins containing holotoxins. J Natl Cancer Inst 77:1247
11. Godal A, Fodstad O, Phil A (1987) Studies on the mechanism of action of abrin-9.2.27 immunotoxin in human melanoma cell lines. Cancer Res 47:6243
12. Godal A, Fodstad O, Pihl A (1988) Kinetics of uptake and degradation of an abrin immunotoxin by melanoma cells and studies of the rates of cellular intoxication. Int J Cancer 42:400
13. Godal A, Kumle B, Pihl A, Juell S, Fodstad O (1992) Immunotoxins directed against the high-molecular-weight melanoma-associated antigen. Identification of potent antibody-toxin combinations. Int J Cancer 52:631
14. Harper JR, Reisfeld RA (1983) Inhibition of anchorage-independent growth of human melanoma cells by a monoclonal antibody to a chondroitin sulfate proteoglycan. J Natl Cancer Inst 71:259-263
15. Harper JR, Quaranta V, Reisfeld RA (1986) Ammonium chloride interferes with a distinct step in the biosynthesis and cell surface expression of human melanoma-type chondroitin sulfate proteoglycan. J Biol Chem 261:3600
16. Iida J, Meijne AML, Spiro RC, Roos E, Furcht LT, McCarthy JB (1995) Spreading and focal contact formation of human melanoma cells in response to the stimulation of both melanoma-associated proteoglycan (NG2) and α4β1 integrin. Cancer Res 55:2177
17. Lauffenburger DA, Linderman JJ (1993) Receptors: models for binding, trafficking and signaling. Oxford University Press, New York p 89
18. Lindmo T, Davies C, Rofstad EK, Fodstad O, Sundan A (1984) Antigen expression in human melanoma cells in relation to growth conditions and cell-cycle distribution. Int J Cancer 33:167
19. Lindmo T, Davies C, Fodstad O, Morgan AC (1984) Stable quantitative differences of antigen expression in human melanoma cells isolated by flow cytometric cell sorting. Int J Cancer 34:507
20. Masuda K, Hirano K, Tagakishi Y (1994) Use of blue-Sepharose for purification of immunotoxin containing type-1 ribosome-inactivating protein, gelonin. Biomed Chromatogr 8:9
21. Menestrina G, Schiavo G, Montecucuco C (1994) Molecular mechanisms of action of bacterial protein toxins. Mol Aspects Med 15:113
22. Morgan AC Jr, Galloway DR, Reisfeld RA (1981) Production and characterization of monoclonal antibody to a melanoma specific glycoprotein. Hybridoma 1:27
23. Morgan AC Jr, Galloway DR, Imai K, Reisfeld RA (1981) Human melanoma-associated antigens: role of carbohydrate in shedding and cell surface expression. J Immunol 126:365
24. Morgan AC Jr, Bordonaro J, Pearson JW, Sivam G (1987) Immunotoxins to a human melanoma-associated antigen: resistance to pokeweed antiviral protein conjugates in vitro. J Natl Cancer Inst 78:1101
25. Pluschke G, Vanek M, Evans A, Dittmar T, Schmid, Itin P, Filardo EJ, Reisfeld RA (1996) Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan. Proc Natl Acad Sci USA 93:9710
26. Saxton RE, Mann BD, Morton DL, Burk MW (1982) Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal defined melanoma antigens. Hybridoma 1:433
27. Schrappe M, Bumol TF, Apelgren LD, Briggs SL, Koppel GA, Markowitz DD, Mueller BM, Reisfeld RA (1992) Long-term growth suppression of human glioma xenografts by chemo-immunoconjugates of 4-desacetylvinblastine-3-carboxyhydrazide and monoclonal antibody 9.2.27. Cancer Res 52:3838
28. Shockley TR, Mandeville JT, Tompkins RG, Yarmush ML (1990) Equilibrium binding characteristics of monoclonal antibodies recognizing melanoma cell surface antigens. Hybridoma 9:527
29. Sivam G, Pearson JW, Bohn W, Oldham RK, Sadoff JC, Morgan AC Jr (1987) Immunotoxins to a human melanoma-associated antigen: comparison of gelonin with ricin and other A chain conjugates. Cancer Res 47:3169
30. Stewart WE (1987) Multiresponse parameter estimation with a new and noninformative prior. Biometrika 74:557
31. Stewart WE, Sorensen JP (1981) Bayesian estimation of common parameters from multiresponse data with missing observations. Technometrics 23:131
32. Trowbridge IS, Omary MB (1981) Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci USA 78:3039
33. Wenning LA, Yazdi PT, Murphy RM (1998) Quantitative analysis of protein synthesis inhibition and recovery in CRM107 immunotoxin-treated HeLa cells. Biotechnol Bioeng 57:484
34. Yazdi PT, Murphy RM (1994) Quantitative analysis of protein synthesis inhibition by transferrin-toxin conjugates. Cancer Res 54:6387
35. Yazdi PT, Wenning LA, Murphy RM (1995) Influence of cellular trafficking on protein synthesis inhibition of immuno-toxins directed against the transferrin receptor. Cancer Res 55:3763